PEPFAR News and Research RSS Feed - PEPFAR News and Research

Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels

Early initiation of antiretroviral therapy can considerably reduce total HIV DNA levels

A team of researchers, led by Drs. Merlin Robb and Jintanat Ananworanich of the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research, has found that when antiretroviral therapy (ART) is initiated during early acute HIV infection, it can significantly reduce total HIV DNA levels in the body, which may have implications for the goal of achieving long-term HIV remission. [More]
Studies shed new light on why young women in South Africa experience high rates of HIV infection

Studies shed new light on why young women in South Africa experience high rates of HIV infection

Evidence by the Centre for the AIDS Programme of Research in South Africa (CAPRISA) consortium of South African and North American researchers will be presented on July 18 at the International AIDS 2016 Conference in Durban, shedding new light on why young women in South Africa have high rates of HIV infection. [More]
WHO and partners launch new strategies to reduce violence against children

WHO and partners launch new strategies to reduce violence against children

WHO and partners today launch 7 interlinked strategies to reduce violence against children. [More]
Study highlights ongoing global epidemic of HIV among gay men

Study highlights ongoing global epidemic of HIV among gay men

Gay, bisexual and other men who have sex with men continue to have disproportionately high burdens of HIV infection in countries of low, middle and high income around the world, a new study led by the Johns Hopkins Bloomberg School of Public Health suggests. [More]
Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Landmark study characterizes evolution of symptoms, signs of acute HIV infection

Acute HIV infection (AHI) contributes significantly to HIV transmission and may be important for intervention strategies seeking to reduce incidence and achieve a functional cure. [More]
Sexual abstinence, marital fidelity programs not effective in reducing HIV risk

Sexual abstinence, marital fidelity programs not effective in reducing HIV risk

The U.S. government has invested $1.4 billion in HIV prevention programs that promote sexual abstinence and marital fidelity, but there is no evidence that these programs have been effective at changing sexual behavior and reducing HIV risk, according to a new Stanford University School of Medicine study. [More]
Study suggests strong treatment programs can help make headway against AIDS epidemic

Study suggests strong treatment programs can help make headway against AIDS epidemic

Botswana appears to have achieved very high rates of HIV diagnosis, treatment, and viral suppression--much better than most Western nations, including the United States--according to a new study from Harvard T.H. Chan School of Public Health and colleagues in Botswana. [More]
Dapivirine ring can help prevent HIV-1 infection in women

Dapivirine ring can help prevent HIV-1 infection in women

In an important scientific achievement for women's health, two large Phase III clinical trials -- The Ring Study and ASPIRE -- have shown that a monthly vaginal ring containing the antiretroviral drug (ARV) dapivirine can safely help prevent HIV-1 infection in women. [More]
New US bipartisan study advocates promoting global health to advance wide range of American interests

New US bipartisan study advocates promoting global health to advance wide range of American interests

A new US bipartisan study advocates promoting global health to both "do the right thing" and advance wide-ranging foreign policy interests. [More]

EGPAF, EJAF launch new project to expand HIV treatment, prevention efforts for adolescents in Africa

The Elizabeth Glaser Pediatric AIDS Foundation and the Elton John AIDS Foundation today launched a new project to expand HIV treatment and prevention efforts for adolescents in urban settings in Kenya and Zambia. [More]
UNITAID report examines new technologies, key market challenges to improved access to better TB diagnostics

UNITAID report examines new technologies, key market challenges to improved access to better TB diagnostics

More than 50 companies are actively developing new products to diagnose tuberculosis (TB), a disease that killed 1.5 million people in 2013, but many countries still rely on older sputum-based methods, according to a report published by UNITAID. [More]
Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex agrees to acquire 51% equity interest in Hema Diagnostic Systems

Generex Biotechnology Corporation today announced that it has entered into a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS), a Florida company that designs and manufactures proprietary infectious disease detection technologies. [More]

HIV cure research may shift from single-therapy development model to combination therapy trials

The next five years of HIV research should shift gears from the classic single-therapy development model to moving directly from in vitro studies to combination therapy trials, authors argue in a new paper published online today. [More]
Panelists to discuss current state of Ebola epidemic at O’Neill Institute Colloquium

Panelists to discuss current state of Ebola epidemic at O’Neill Institute Colloquium

The O'Neill Institute for National and Global Health Law fall colloquium series continues Wednesday, Sept. 16 with a focus on Ebola. [More]
Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

Multiple HIV-1 variants at the beginning of infection impact viral load setpoints

HIV-1 infection with multiple founder variants points to poorer clinical outcomes than infection with a single variant, according to a paper published today in the journal Nature Medicine. [More]
CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD announces new funding agreement to increase HIV prevention products for high risk women in Africa

CONRAD is pleased to announce a new funding agreement, in collaboration with the U.S. President's Emergency Plan for AIDS Relief and the U.S. Agency for International Development, in support of a human centered design (HCD) strategy to increase demand, use and adherence of HIV prevention products for high risk women in Africa. [More]

New report highlights key success in global response to preventing AIDS in women, children

The Elizabeth Glaser Pediatric AIDS Foundation applauds today's announcement from the Joint United Nations Programme on HIV/AIDS that the goal of providing 15 million people with lifesaving antiretroviral therapy (ART) by 2015 has been met nine months ahead of schedule. [More]
WHO prequalifies new male circumcision device to prevent HIV

WHO prequalifies new male circumcision device to prevent HIV

The ShangRing, a novel medical device for voluntary medical male circumcision, has received prequalification from the World Health Organization (WHO) for use. [More]

Tentative FDA approval of lopinavir/ritonavir oral pellet formulation closes treatment gap for children with HIV

Infants and young children living with HIV will finally have access to an improved formulation of an antiretroviral (ARV) treatment, following the U.S. Food and Drug Administration's tentative approval last week of lopinavir/ritonavir (LPV/r) oral pellets developed by the Indian generic company Cipla. [More]
Sexual violence against children significantly higher in low- and middle-income countries

Sexual violence against children significantly higher in low- and middle-income countries

Sexual violence against children is a significant problem in many low- and middle-income countries. At least 25 percent of females and 10 percent of males experienced some form of childhood sexual violence in the majority of seven countries studied, according to findings from the Violence Against Children Surveys (VACS) released today in the Morbidity and Mortality Weekly Report (MMWR) by the Centers for Disease Control and Prevention. [More]
Advertisement
Advertisement